Gonorrhea Global Clinical Trials Review, H2, 2017

Price :
Published : Aug-2017
No. of Pages : 58

Gonorrhea Global Clinical Trials Review, H2, 2017


GlobalData’s clinical trial report, “Gonorrhea Global Clinical Trials Review, H2, 2017” provides an overview of Gonorrhea clinical trials scenario. This report provides top line data relating to the clinical trials on Gonorrhea. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Filed in: Pharmaceutical
Publisher : GlobalData
More Reports
Title Price Buy Now

Vaccinex Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Vaccinex Inc (Vaccinex) is a clinical-stage biotechnology company that focuses on the discovery and development of targeted biotherapeutics to treat neurodegenerative diseases, cancer and autoimmune disorders. The company's lead platform technologies include SEMA4D, antibody platform and ActivMAb, antibody discovery platform. Vaccinex through its antibody platform develops its lead product candidate, VX15, for the treatment of various indications, including neurodegenerative diseases, neuroinflammatory and cancer. The company also develops VX5, which is in preclinical development for the treatment of autoimmune disorders. It has partnership with various biotechnology and biopharmaceutical companies, to enhance its product candidates. Vaccinex is headquartered in Rochester, New Y......

Biovista Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Biovista Inc (Biovista) is a drug development company that provides COSS platform technology support in uncovering non-obvious correlations between drugs. The company's products are used for the treatment of neurodegenerative diseases, epilepsy, oncology and orphan diseases. It offers services such as drug repositioning and loss of exclusivity, benefit and risk assessment, and others. Biovista's drug candidates include BVA201, BVA202 and BVA203. The company undertakes research in areas such as orphan diseases, drug de-risking, personalized medicine, opinion mining, systematic discovery support and linguistics. It operates in various parts of Europe. Biovista is headquartered in Charlottesville, Virginia, the US. Biovista Inc - Pharmaceuticals & Healthcare - Deals and Alliance......

Eternygen GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Eternygen GmbH (Eternygen) focuses on research and development of innovative drugs for dietary-related metabolic diseases.The company's product development portfolio includes novel small molecule inhibitors, developed against the sodium coupled citrate transporter NaCT. It focuses research on NaCT, a regulator of lipid metabolism involved in the pathogenesis. Eternygen provides drugs for diseases such as fatty liver, diabetes mellitus and obesity. Its proprietary molecules work on glucose metabolism and hepatic lipid oxidation and acts as a therapeutic target by influencing the mammalian energy metabolism. The company works in collaboration with other contract research organizations for drug discovery and pre-clinical development in the field of metabolic diseases. Eternygen is ......

PanOptica Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary PanOptica Inc (PanOptica) is a biopharmaceutical company that develops new ocular therapies in the field of ophthalmology. The company concentrates on candidates that are at or near the investigational new drug application stage. It licenses and develops novel therapeutics that can improve existing therapies for previously untreatable ophthalmic disorders. PanOptica is developing a novel, small-molecule selective vascular endothelial growth factor receptor antagonist, which targets the treatment of wet age-related macular degeneration and diabetic retinopathy. The company also partners biopharmaceutical companies to complete development, regulatory approval, and commercialization of the compound. PanOptica is headquartered in Bernardsville, New Jersey, the US. PanOptica Inc -......

Mediolanum farmaceutici SpA – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Mediolanum farmaceutici SpA (Mediolanum) is a healthcare solution provider that discovers, develops and markets pharmaceuticals products and prescription drugs. The company offers products in therapeutic areas which include neuropsychiatric, osteoarticular, antibiotic, pneumoallergological, vascular area and cardiometabolic areas. It offers products for neuropsychiatric area, which include anxiety, depression and migraine. Mediolanum provides products for vascular area which include peripheral obliterant arteriopathy and chronic venous insufficiency. The company provides research and development services to discover new drugs. It invests in various patents and projects in several areas such as endocrinology, rheumatoid arthritis, vaccines for prostate and kidney cancer, and othe......

Michael J Fox Foundation for Parkinson’s Research – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Michael J Fox Foundation for Parkinson's Research (Michael J. Fox) is a research foundation that conducts research on Parkinson's disease. The foundation offers research and development of therapies. It provides drug development and other research activities in the area of Parkinson's disease. Michael J. Fox offers treatments, which include deep brain stimulation, medication and therapy development. The foundation operates through drug development service companies, pharmaceuticals and healthcare centers. It collaborates with other companies to enhance its research programs through funding, in-kind contributions, strategic input, and others. Michael J. Fox is headquartered in New York, the US. Michael J Fox Foundation for Parkinson's Research - Pharmaceuticals & Healthcare - ......

Dauntless Pharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Dauntless Pharmaceuticals Inc (Dauntless) is a biotech company that develops therapeutic agents. The company's pipeline product include DP1038, a therapeutic agent used for the treatment of endocrine cancers. It operates through various stages of development. Dauntless manages the development of multiple clinical assets that enables the optimal structuring of financial, human, and development resources as well as acquisitions and partnerships. The company's key investors include life science company. It also provides additional drug candidates to expand the pipeline. The company partners with pharmaceutical and biotech industries. Dauntless is headquartered in San Diego, California, the US. Dauntless Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Pro......

Centene Corp (CNC) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Centene Corp (Centene) is a healthcare service provider that offers services to government sponsored healthcare programs with focus on under-insured and uninsured individuals. It provides health plans through Medicaid, Medicare and Health Insurance Marketplace contracts; and other health solutions through its specialty services companies. It provides a comprehensive range of managed healthcare products and services including Medicaid, the State Children's Health Insurance Program (CHIP), Long Term Care (LTC), Foster Care, dual-eligible individuals (Duals), the Supplemental security income program a/k/a the Aged, blind or disabled program (ABD), Medicare and Health Insurance Marketplace. Centene through its Specialty Services companies offers life and health management, behaviora......

Serina Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Serina Therapeutics Inc (Serina Therapeutics) is a drug company that develops therapeutics for cancer, inflammation, pain, and metabolic disorders. The company's pipeline product includes SER-214, SER-226, SER-228, SER-232, and other proprietary drugs. It uses proprietary technology, polyoxazoline (POZ), for drug development. Serina Therapeutics partners its POZ platform with other companies to develop pharmaceuticals, which include antibody drug conjugates, proteins and small molecules. The company's propietary drugs are used in the treatment of neurological diseases, cancer and pain. It partners with others pharmaceutical and biotechnology companies to develop novel therapeutics. Serina Therapeutics is headquartered in Huntsville, Alabama, the US. Serina Therapeutics Inc - ......

PIQUR Therapeutics AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary PIQUR Therapeutics AG (PIQUR) is a clinical-stage pharmaceutical company that discovers and develops anti-cancer drugs. The company develops innovative small molecule therapeutics based on lipid kinase (PI3K) and mTOR inhibitior for the treatment of cancer and inflammatory diseases. Its pipeline products include PQR-309, PQR-620, PQR-530, PQR-514, PQR-6XX, and PI3K/mTOR inhibitors. PIQUR's lead compound PQR309, is a potent small molecule with balanced pan-PI3K/mTOR selectivity. The company's target therapy areas include oncology, central nervous system, ophthalmology, and dermatology, among others. It conducts research in the areas of oncology. PIQUR serves patients and the medical community. The company partners with pharmaceutical and biotech companies. PIQUR is headquartered ......